NARA Discovery
Article Details
← Back to Search Results
Journal Article

A novel physiologically-based pharmacokinetic model to estimate reduced CYP3A4 activity in cancer patients utilizing the neutrophil-to-lymphocyte ratio as an inflammatory marker

David E. Coutant; Jessica Rehmel; Donna M. Edwards; Stephen D. Hall
European Journal of Clinical Pharmacology · Vol. 81, Issue 6 · pp. 853-862 · 2025

Abstract

Abstract is unavailable.

Bibliographic Information

JournalEuropean Journal of Clinical Pharmacology
PublisherSpringer
Publication Date2025-06-01
Publication Year2025
Volume81
Issue6
Pages853-862
Document TypeJournal Article
Print ISSN0031-6970
eISSN1432-1041
DOI10.1007/s00228-025-03839-1

Access Information

NARA Access Coverage1968-01-01~Current
Journal Homepagehttps://www.springer.com/journal/228
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.